These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12040531)

  • 21. Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation.
    Kaya H; Keung YK; Case D; Cruz JM; Perry JJ; Radford JE; Hurd DD
    Biol Blood Marrow Transplant; 2002; 8(10):544-9. PubMed ID: 12434949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
    Pettengell R
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.
    Gianni AM; Cortelazzo S; Magni M; Martelli M;
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S10-3. PubMed ID: 11840155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hematopoietic stem cell transplantation for malignant lymphoma].
    Asaoku H
    Nihon Rinsho; 2000 Mar; 58(3):704-8. PubMed ID: 10741150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
    Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating monoclonal antibodies into the management of mantle cell lymphoma.
    Berinstein NL; Mangel J
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):2-6. PubMed ID: 15042527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.
    Grigg AP; Bashford J; Seymour JF; Shuttleworth P; Norris D; Hertzberg M; Gill D; Waugh M; Saal R; Marlton P
    Leuk Lymphoma; 2005 Jun; 46(6):851-60. PubMed ID: 16019529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.
    Voso MT; Pantel G; Weis M; Schmidt P; Martin S; Moos M; Ho AD; Haas R; Hohaus S
    Br J Haematol; 2000 Jun; 109(4):729-35. PubMed ID: 10929022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
    Tam CS; Bassett R; Ledesma C; Korbling M; Alousi A; Hosing C; Kebraei P; Harrell R; Rondon G; Giralt SA; Anderlini P; Popat U; Pro B; Samuels B; Hagemeister F; Medeiros LJ; Champlin RE; Khouri IF
    Blood; 2009 Apr; 113(18):4144-52. PubMed ID: 19168784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation.
    Cairoli R; Grillo G; Tedeschi A; D'Avanzo G; Marenco P; Morra E
    Haematologica; 2004 Mar; 89(3):361-3. PubMed ID: 15020279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
    Kolstad A; Pedersen LB; Eskelund CW; Husby S; Grønbæk K; Jerkeman M; Laurell A; Räty R; Elonen E; Andersen NS; Brown PD; Kimby E; Bentzen H; Sundström C; Ehinger M; Karjalainen-Lindsberg ML; Delabie J; Ralfkiær E; Fagerli UM; Nilsson-Ehle H; Lauritzsen GF; Kuittinen O; Niemann C; Geisler CH;
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):428-435. PubMed ID: 28039078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of hematopoietic stem cell transplant in the management of follicular lymphoma.
    Foster M; Gabriel DA; Shea T
    Oncologist; 2009 Jul; 14(7):726-38. PubMed ID: 19561292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
    Robinson S; Dreger P; Caballero D; Corradini P; Geisler C; Ghielmini M; Le Gouill S; Kimby E; Rule S; Vitolo U; Dreyling M; Hermine O;
    Leukemia; 2015 Feb; 29(2):464-73. PubMed ID: 25034148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.
    Andersen NS; Donovan JW; Zuckerman A; Pedersen L; Geisler C; Gribben JG
    Exp Hematol; 2002 Jul; 30(7):703-10. PubMed ID: 12135667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Naparstek E
    Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous transplant of follicular lymphoma in the era of rituximab.
    Witzens-Harig M; Dreger P
    Leuk Lymphoma; 2010 Jun; 51(6):967-74. PubMed ID: 20443675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Lin TS; Copelan EA
    Curr Hematol Rep; 2003 Jul; 2(4):310-5. PubMed ID: 12901328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.